SMTL ID : 4iax.1

Engineered human lipocalin 2 (CL31) in complex with Y-DTPA

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x LIZ: N-{(1S,2S)-2-[bis(carboxymethyl)amino]cyclohexyl}-N-{(2R)-2-[bis(carboxymethyl)amino]-3-[4-({[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]carbamothioyl}amino)phenyl]propyl}glycine(Non-covalent)

LIZ.1: 16 residues within 4Å: Chain A: Q.33, R.36, T.52, Q.54, V.66, A.68, R.70, E.77, Y.78, L.79, M.81, F.83, Y.106, F.123, S.136 Ligands: YT3.2 21 PLIP interactions: 21 interactions with chain A Hydrophobic interactions: A:V.66, A:A.68, A:R.70, A:L.79, A:L.79, A:M.81, A:F.83 Hydrogen bonds: A:Q.33, A:T.52, A:Q.54, A:Y.78, A:Y.78, A:Y.106, A:S.136 Water bridges: A:K.125, A:S.134, A:S.134 Salt bridges: A:R.36, A:K.125, A:K.125 pi-Cation interactions: A:R.70

1 x YT3: YTTRIUM (III) ION(Non-functional Binders)

YT3.2: 1 residues within 4Å: Ligands: LIZ.1 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Eggenstein, E. et al., Structure-guided engineering of Anticalins with improved binding behavior and biochemical characteristics for application in radio-immuno imaging and/or therapy. J.Struct.Biol. (2014)

Release Date

2013-06-19

Peptides

Neutrophil gelatinase-associated lipocalin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Neutrophil gelatinase-associated lipocalin